Evaluation of oral administration of Peganum in nocturia in patients with benign prostatic hyperplasia
Phase 3
- Conditions
- Hyperplasia of prostate.Hyperplasia of prostate
- Registration Number
- IRCT2014091419151N1
- Lead Sponsor
- Vice chancellor for research of Shahrekord University of Medical Scie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
patients with benign prostatic enlargement.
Exclusion criteria: patients undergoing surgery; a significant anomaly functional or anatomical urinary tract; thyroid dysfunction; prostate cancer; patients with mental disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease of nocturia. Timepoint: 1 months latter. Method of measurement: examination.
- Secondary Outcome Measures
Name Time Method